Ke Ning

5.9k total citations
113 papers, 4.3k citations indexed

About

Ke Ning is a scholar working on Molecular Biology, Genetics and Biomedical Engineering. According to data from OpenAlex, Ke Ning has authored 113 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Molecular Biology, 16 papers in Genetics and 16 papers in Biomedical Engineering. Recurrent topics in Ke Ning's work include Neurogenetic and Muscular Disorders Research (12 papers), 3D Printing in Biomedical Research (11 papers) and RNA modifications and cancer (10 papers). Ke Ning is often cited by papers focused on Neurogenetic and Muscular Disorders Research (12 papers), 3D Printing in Biomedical Research (11 papers) and RNA modifications and cancer (10 papers). Ke Ning collaborates with scholars based in China, United Kingdom and United States. Ke Ning's co-authors include John C. Reed, Yama Abassi, Daniel F. Voytas, Xiao Yun Xu, Adam Godzik, Xiaobo Wang, Pamela J. Shaw, Mimoun Azzouz, Chiara F. Valori and Matthew Wyles and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Medicine.

In The Last Decade

Ke Ning

109 papers receiving 4.2k citations

Peers

Countries citing papers authored by Ke Ning

Since Specialization

Citations

This map shows the geographic impact of Ke Ning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ke Ning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ke Ning more than expected).

Fields of papers citing papers by Ke Ning

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ke Ning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ke Ning. The network helps show where Ke Ning may publish in the future.

Co-authorship network of co-authors of Ke Ning

This figure shows the co-authorship network connecting the top 25 collaborators of Ke Ning. A scholar is included among the top collaborators of Ke Ning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ke Ning. Ke Ning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	A mirror-assisted imaging device enables side-view observation of microscale changes at interface without modifying the microscope 2025 ·Measurement ·Ke Ning, Can Fang, Yuanyuan Xie, Qianwei Chen, Li Feng, Rong Pan, Ling Yu	0
2	3D cell spheroid inoculated with bacteria: An in vitro model for assessing antimicrobial efficacy 2025 ·Journal of Biotechnology ·(unknown), Ke Ning, Li Feng, Yi‐Rong Chen, Yuanyuan Xie, (unknown), Ling Yu	1
3	A pump-free dual unidirectional circulation microfluidic device for tumor spheroid microenvironment modulation and motility analysis 2025 ·Microchemical Journal ·Xiaoqing Chen, Yuanyuan Xie, (unknown), Ke Ning, Yi‐Rong Chen, Li Feng, Can Fang, Yan Li, Ling Yu	0
4	Lipid-based nanoparticles for drug delivery in Parkinson’s disease 2024 ·Translational Neuroscience ·Han Cai, Dong Liu, Weiwei Xue, (unknown), (unknown), Ke Ning	5
5	High throughput generating stable spheroids with tip‐refill wafer 2024 ·Biotechnology Journal ·(unknown), (unknown), Ke Ning, Yuanyuan Xie, Feng Chen, Wei Sun, Ling Yu	1
6	Non-destructive in situ monitoring of structural changes of 3D tumor spheroids during the formation, migration, and fusion process 2024 ·eLife ·Ke Ning, Yuanyuan Xie, (unknown), Li Feng, Can Fang, (unknown), Yan Li, Ling Yu	5
7	The impact of 3D tumor spheroid maturity on cell migration and invasion dynamics 2024 ·Biochemical Engineering Journal ·Li Feng, (unknown), Ke Ning, (unknown), Yi‐Rong Chen, Yuanyuan Xie, (unknown), Yan Li, Ling Yu	6
8	Label-Free and Real-Time Optical Detection of Affinity Binding of the Antibody on Adherent Live Cells 2024 ·Analytical Chemistry ·Xiaoyi Li, Shiming Wu, Zhihao Feng, Ke Ning, Dandan Ji, Ling Yu, Weihua Hu	3
9	Internet use, dietary habits and adolescent obesity: evidence from China 2024 ·International Journal of Health Economics and Management ·Ke Ning, (unknown), Zhigang Xu, Haiyan Liu, (unknown)	0
10	An easy-to-open multi-chamber device to study the molecular changes behind the plant root microscale phenotypic variations 2023 ·Sensors and Actuators B Chemical ·Huihui Chai, Feng Chen, Ke Ning, (unknown), Ling Yu	1
11	SMURF1 inhibits the Th17 and Th17.1 polarization and improves the Treg/Th17 imbalance in systemic lupus erythematosus through the ubiquitination of RORγt 2023 ·Molecular Immunology ·Wei Zhong, (unknown), Wei Tian, Hongbo Qu, Haibo Xu, Ke Ning, (unknown), Wei Liu, Xiaowei Gong, (unknown)	1
12	Biochar with nanoparticle incorporation and pore engineering enables enhanced heavy metals removal 2023 ·Journal of environmental chemical engineering ·(unknown), Lingjie Zhang, Ke Ning, Weiran Yang	12
13	Using pipette tips to readily generate spheroids comprising single or multiple cell types 2023 ·Journal of Zhejiang University. Science A ·(unknown), (unknown), Shiming Wu, Yuanyuan Xie, Feng Chen, Ke Ning, Wei Sun, Ling Yu	3
14	Recapitulating the Drifting and Fusion of Two-Generation Spheroids on Concave Agarose Microwells 2023 ·International Journal of Molecular Sciences ·(unknown), (unknown), Ke Ning, Yuanyuan Xie, Feng Chen, Ling Yu	9
15	A Case Report of Plasmablastic Lymphoma with Unusual Presentation: How Do Socioeconomic Factors Contribute to Cancer Survival? 2022 ·(unknown), (unknown), (unknown), Alan R. King, Ke Ning	1
16	Defining the signalling determinants of a posterior ventral spinal cord identity in human neuromesodermal progenitor derivatives 2021 ·Development ·(unknown), (unknown), Ichcha Manipur, Ilaria Granata, (unknown), Peter W. Andrews, Ivana Barbaric, Ke Ning, Mario Rosario Guarracino, Marysia Placzek, Anestis Tsakiridis	15
17	SRSF1-dependent inhibition of C9ORF72-repeat RNA nuclear export: genome-wide mechanisms for neuroprotection in amyotrophic lateral sclerosis 2021 ·Molecular Neurodegeneration ·Lydia M. Castelli, Luisa Cutillo, Cleide Dos Santos Souza, Álvaro Sánchez-Martínez, Ilaria Granata, Ya-Hui Lin, Monika A. Myszczynska, Paul R. Heath, Matthew R. Livesey, Ke Ning, Mimoun Azzouz, Pamela J. Shaw, Mario Rosario Guarracino, Alexander J. Whitworth, Laura Ferraiuolo, Marta Milo, Guillaume M. Hautbergue	16
18	Differentiation of Human Adipose-Derived Stem Cells into Neuron-Like Cells Which Are Compatible with Photocurable Three-Dimensional Scaffolds 2013 ·Tissue Engineering Part A ·Shane Gao, Peng Zhao, Chao Lin, Yuxi Sun, Yilei Wang, (unknown), Danjing Yang, Xianli Wang, (unknown), Fei Zhou, Limei Cao, Wei Zhou, Ke Ning, Xu Chen, Jun Xu	69
19	Orphan G protein–coupled receptor GPR56 plays a role in cell transformation and tumorigenesis involving the cell adhesion pathway 2007 ·Molecular Cancer Therapeutics ·Ke Ning, Roshni Sundaram, Guohong Liu, John Chionis, Wufang Fan, (unknown), Tarif Awad, Mirta Grifman, Dehua Yu, Flossie Wong‐Staal, Qi‐Xiang Li	60
20	A 96-Well Surrogate Survival Assay Coupled with a Special Short Interfering RNA Vector for Assessing Cancer Gene Targets with Enhanced Signal/Noise Ratio and Its Utility in HTS for Cancer Therapeutic Targets 2005 ·Assay and Drug Development Technologies ·Dehua Yu, Jon E. Chatterton, Joshua Bliesath, Roshni Sundaram, Ke Ning, (unknown), Bernd Meyhack, Flossie Wong‐Staal, Qi‐Xiang Li	12

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact